3-181712413-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_003106.4(SOX2):c.53C>A(p.Ser18Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000314 in 1,593,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. S18S) has been classified as Benign.
Frequency
Consequence
NM_003106.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOX2 | NM_003106.4 | c.53C>A | p.Ser18Ter | stop_gained | 1/1 | ENST00000325404.3 | NP_003097.1 | |
SOX2-OT | NR_075091.1 | n.783-2772C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOX2 | ENST00000325404.3 | c.53C>A | p.Ser18Ter | stop_gained | 1/1 | NM_003106.4 | ENSP00000323588 | P1 | ||
SOX2-OT | ENST00000626948.3 | n.837-2772C>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151684Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000191 AC: 4AN: 209562Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 115112
GnomAD4 exome AF: 0.00000278 AC: 4AN: 1441354Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 715260
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151684Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74054
ClinVar
Submissions by phenotype
Anophthalmia/microphthalmia-esophageal atresia syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2019 | This sequence change results in a premature translational stop signal in the SOX2 gene (p.Ser18*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 300 amino acids of the SOX2 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individual(s) with bilateral anophthalmia (PMID: 17522144, 25542770). In at least one individual the variant was observed to be de novo. This variant disrupts the C-terminus of the SOX2 protein. Other variant(s) that disrupt this region (p.Gly31Alafs*23, p.Asn24Argfs*65) have been determined to be pathogenic (PMID: 18285410, 24804704, 26250054, 27206652, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at